These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 16791027)

  • 1. Risk factors for active tuberculosis in adults on highly active antiretroviral therapy in Africa.
    Seyler C; Toure S; Messou E; Anglaret X
    AIDS; 2006 Jun; 20(10):1463; author reply 1463-5. PubMed ID: 16791027
    [No Abstract]   [Full Text] [Related]  

  • 2. Reduced risk of tuberculosis among Brazilian patients with advanced human immunodeficiency virus infection treated with highly active antiretroviral therapy.
    Santoro-Lopes G; de Pinho AM; Harrison LH; Schechter M
    Clin Infect Dis; 2002 Feb; 34(4):543-6. PubMed ID: 11797184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of antiretroviral therapy on tuberculosis risk in different TB-HIV epidemics.
    Middelkoop K
    Int J Tuberc Lung Dis; 2010 Mar; 14(3):261. PubMed ID: 20132613
    [No Abstract]   [Full Text] [Related]  

  • 4. The sound of one hand clapping: tuberculosis and antiretroviral therapy in Africa.
    De Cock KM; Marston B
    Am J Respir Crit Care Med; 2005 Jul; 172(1):3-4. PubMed ID: 15980107
    [No Abstract]   [Full Text] [Related]  

  • 5. Trends in opportunistic infections in the pre- and post-highly active antiretroviral therapy eras among HIV-infected children in the Perinatal AIDS Collaborative Transmission Study, 1986-2004.
    Nesheim SR; Kapogiannis BG; Soe MM; Sullivan KM; Abrams E; Farley J; Palumbo P; Koenig LJ; Bulterys M
    Pediatrics; 2007 Jul; 120(1):100-9. PubMed ID: 17606567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies further identify risks for TB while on HAART.
    McCord A
    Proj Inf Perspect; 2008 Sep; (46):15-7. PubMed ID: 19048674
    [No Abstract]   [Full Text] [Related]  

  • 7. Trends in bacteremia in the pre- and post-highly active antiretroviral therapy era among HIV-infected children in the US Perinatal AIDS Collaborative Transmission Study (1986-2004).
    Kapogiannis BG; Soe MM; Nesheim SR; Sullivan KM; Abrams E; Farley J; Palumbo P; Koenig LJ; Bulterys M
    Pediatrics; 2008 May; 121(5):e1229-39. PubMed ID: 18450865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Issues in the management of HIV-related tuberculosis.
    Burman WJ
    Clin Chest Med; 2005 Jun; 26(2):283-94, vi-vii. PubMed ID: 15837111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV-related mortality among tuberculosis patients in The Netherlands, 1993-2001.
    Haar CH; Cobelens FG; Kalisvaart NA; van Gerven PJ; van der Have JJ
    Int J Tuberc Lung Dis; 2007 Sep; 11(9):1038-41. PubMed ID: 17918662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastroduodenal opportunistic infections and dyspepsia in HIV-infected patients in the era of Highly Active Antiretroviral Therapy.
    Werneck-Silva AL; Prado IB
    J Gastroenterol Hepatol; 2009 Jan; 24(1):135-9. PubMed ID: 19054257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV-associated tuberculosis in the era of HAART.
    Pozniak A
    Int J Tuberc Lung Dis; 2000 Nov; 4(11):993-4. PubMed ID: 11092707
    [No Abstract]   [Full Text] [Related]  

  • 12. [HIV and tuberculosis: new perspectives for diagnosis and treatment].
    Zellweger JP
    Rev Med Suisse; 2006 Nov; 2(87):2616-9. PubMed ID: 17343152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 'Tuberculosis' after commencing antiretroviral therapy in HIV patients from countries where Mycobacterium tuberculosis infection is common.
    French MA
    AIDS; 2006 Feb; 20(3):473-4. PubMed ID: 16439889
    [No Abstract]   [Full Text] [Related]  

  • 14. Tuberculosis control in South Africa--will HAART help?
    Lawn SD; Wood R
    S Afr Med J; 2006 Jun; 96(6):502-4. PubMed ID: 16841129
    [No Abstract]   [Full Text] [Related]  

  • 15. Bacterial community acquired pneumonia in HIV-infected inpatients in the highly active antiretroviral therapy era.
    Madeddu G; Porqueddu EM; Cambosu F; Saba F; Fois AG; Pirina P; Mura MS
    Infection; 2008 Jun; 36(3):231-6. PubMed ID: 18463787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The continuing challenge of opportunistic infections.
    Scoular A
    J HIV Ther; 2002 Feb; 7(1):1. PubMed ID: 11956496
    [No Abstract]   [Full Text] [Related]  

  • 17. Opportunistic infection associated to HIV/AIDS in Nepal.
    Arijit G; Shalini C
    Med J Malaysia; 2007 Mar; 62(1):88. PubMed ID: 17682586
    [No Abstract]   [Full Text] [Related]  

  • 18. Tuberculosis in Africa--combating an HIV-driven crisis.
    Chaisson RE; Martinson NA
    N Engl J Med; 2008 Mar; 358(11):1089-92. PubMed ID: 18337598
    [No Abstract]   [Full Text] [Related]  

  • 19. Multidrug-resistant and extensively drug-resistant tuberculosis: implications for the HIV epidemic and antiretroviral therapy rollout in South Africa.
    Andrews JR; Shah NS; Gandhi N; Moll T; Friedland G;
    J Infect Dis; 2007 Dec; 196 Suppl 3():S482-90. PubMed ID: 18181698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in the clinical spectrum of opportunistic illnesses in persons with HIV infection in Taiwan in the era of highly active antiretroviral therapy.
    Sun HY; Chen MY; Hsieh SM; Sheng WH; Chang SY; Hsiao CF; Hung CC; Chang SC
    Jpn J Infect Dis; 2006 Oct; 59(5):311-6. PubMed ID: 17060697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.